Jubilant Life Sciences explores acquisition of US-based pharma biz

March 21, 2017 | Joseph Rai

Pharmaceutical and life sciences firm Jubilant Life Sciences Ltd will explore an acquisition of a specialty pharma business in the US.

The acquisition will be done through the firm's Singapore-based wholly-owned subsidiary Jubilant Pharma Ltd, it said in a stock market disclosure. 

Indian drugmakers face squeeze in US on fears of tougher rules

March 17, 2017 | Reuters

India's small and medium-sized generic drugmakers say the threat of tougher rules and higher barriers for outsiders in the U.S. healthcare market will force many to find a niche or focus their expansion efforts on other countries.

Sun Pharma's arm to acquire Canadian drug firm Thallion

March 17, 2017 | Joseph Rai

India's biggest drugmaker Sun Pharmaceutical Industries Ltd has agreed to acquire Canadian pharmaceuticals firm Thallion Pharmaceuticals Inc for 2.7 million Canadian dollars (around $2 million).

Exclusive: Top PE firms eye ChrysCapital’s stake in Intas Pharma

March 14, 2017 | Ranjani Raghavan

Several private equity investors are in the fray for PE firm ChrysCapital Investment Advisors Pvt. Ltd’s stake in Intas Pharmaceuticals Ltd, three persons familiar with the development told VCCircle.

TA Associates backs pharma products supplier Ideal Cures

March 14, 2017 | Ranjani Raghavan

Private equity firm TA Associates said on Tuesday it has invested in Mumbai-based Ideal Cures Pvt. Ltd, its second bet on a pharmaceuticals company within three months.

Exclusive: Torrent Pharma buying select products of Novartis in India

March 09, 2017 | Joseph Rai

Ahmedabad-based drugmaker Torrent Pharmaceuticals Ltd has agreed to acquire some of the products of global healthcare company Novartis in India, VCCircle has learnt.

Delhi HC restrains former Ranbaxy promoters to dilute or sell assets

March 07, 2017 | Maulik Vyas

The Delhi High Court, on Monday, directed former promoters of Ranbaxy Laboratories Ltd, Malvinder Mohan Singh and Shivinder Mohan Singh, to disclose their assets within a week, while restraining them from selling any asset without the court’s permission.

Cipla to sell South African animal health business for $29 mn

March 06, 2017 | Ranjani Raghavan

Mumbai-headquartered pharmaceutical major Cipla Ltd has agreed to sell its animal health business in South Africa to Ascendis Health Ltd for ZAR 375 million ($29 million), the company said in a statement.

Exclusive: Century Pharma hires banker for fresh fundraise; existing investor to exit

February 28, 2017 | Joseph Rai

Drugmaker Century Pharmaceuticals Ltd has hired an investment bank as it seeks to raise fresh funds and give a full exit to its existing investor which put in money in the firm nine years ago, two persons aware of the development told VCCirlce.

Exclusive: Cipla hires former Dr. Reddy's exec as general counsel

February 27, 2017 | Maulik Vyas

Mumbai-based generic drugmaker Cipla Ltd has hired a former executive at Dr Reddy’s Laboratories Ltd as its global general counsel to fill a post that had been lying vacant for almost a year, a person familiar with the development told VCCircle.



Upcoming Events